PROCESS FOR THE SELECTIVE MODULATION OF THE EXPRESSION AND FUNCTION OF A DETERMINANT ON THE CELL SURFACE BY MEANS OF APPROPRIATE CHEMICAL AGENTS

摘要

Use of N-dichloroacetyl lysoganyliosides, e.g. Ndichloroacetyl lyso GM1, in the manufacture or preparation of a pharmaceutical formulation for selectively modulating the CD4 determinant present on the surface of human cells. This modulation can be used therapeutically to treat neuroimmunopathological conditions or neuroimmunopathology associated with infection by viruses e.g. the HIV-I virus.